Loss of In Vivo Replication Fitness of HIV-1 Variants Resistant to the Tat Inhibitor, dCA
HIV resistance to the Tat inhibitor didehydro-cortistatin A (dCA) in vitro correlates with higher levels of Tat-independent viral transcription and a seeming inability to enter latency, which rendered resistant isolates more susceptible to CTL-mediated immune clearance. Here, we investigated the abi...
Main Authors: | Lijun Ling, Ana R. Leda, Nurjahan Begum, Rae Ann Spagnuolo, Angela Wahl, J. Victor Garcia, Susana T. Valente |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-04-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/15/4/950 |
Similar Items
-
Didehydro-Cortistatin A Inhibits HIV-1 by Specifically Binding to the Unstructured Basic Region of Tat
by: Sonia Mediouni, et al.
Published: (2019-02-01) -
The Optimal Choice of Technique for Stereotactic Radiosurgery—A LINAC-Based Dosimetric Study between DCA, DCA-SSO, DCA-SSO-VDR, and VMAT
by: Ramya Venugopal, et al.
Published: (2022-07-01) -
Comparative Analysis of Tat-Dependent and Tat-Deficient Natural Lentiviruses
by: Deepanwita Bose, et al.
Published: (2015-09-01) -
Strategies to Block HIV Transcription: Focus on Small Molecule Tat Inhibitors
by: Susana Valente, et al.
Published: (2012-11-01) -
hoDCA: higher order direct-coupling analysis
by: Michael Schmidt, et al.
Published: (2018-12-01)